-
Apollo Hospitals
6,900.70 5,690.80(%) -
Waaree Energies
2,590.20 1,808.65(%) -
Reliance Industr
1,288.00 1,115.55(%) -
SpiceJet
55.49 79.90(%) -
Axis Bank
1,145.75 934.00(%) -
Dixon Technolog.
16,092.55 7,935.00(%) -
Suzlon Energy
56.78 37.95(%) -
Vodafone Idea
7.44 6.60(%) -
SBI Life Insuran
1,763.00 1,935.00(%) -
Tata Motors
651.45 542.55(%) -
Bharat Electron
293.70 221.00(%) -
Tata Power Co.
382.00 326.25(%) -
Reliance Power
40.91 23.26(%) -
Eternal Ltd
226.95 146.85(%) -
HDFC Bank
1,891.90 1,430.15(%) -
Jio Financial
249.15 198.60(%) -
Mazagon Dock
2,585.00 1,046.00(%) -
Adani Energy Sol
907.00 588.25(%) -
Nip. India Nifty
266.61 242.12(%) -
Adani Green
904.00 758.00(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Tatva Chintan Pharma Chem Ltd Chemicals
- Indian Private
- BSE Code : 75545.0
- ISIN : INE0GK401011
-
Today’s Low
714.60 -
Today’s High
783.00

-
Open
760.85 -
Perv Close
760.85 -
52W Low
621.00 -
52W High
1,283.70
Key Indicators
-
P/E(TTM)
226.77
-
Mar.Cap (₹Cr.)
1,697.09
-
Div & Yield %
0.28
-
Book Value(₹)
308.43
-
Debt-Equity Ratio
-4.65
-
AGM Date
25-Apr-2025
-
EPS
3.20
-
P/E Ratio
226.77
Financials Ratios
-
Debt-Equity Ratio
0.15
-
Mar.Cap (₹Cr.)
1,697.09
-
RONW (%)
4.85
-
ROCE (%)
6.99
Score Board
-
Equity (₹ in Cr.)
23.39
-
BV (₹)
308.40
-
Sales( ₹ in Cr.)
378.68
-
NP (in Cr.)
29.41
-
NP Var(%)
-33.0
-
Div%
20.0
-
CPS (₹)
23.50
-
EPS (₹)
12.60
-
Traded Value (₹ in Lakhs)
1,697.44
-
52 Week High
1,283.70
-
52 Week Low
621.00
-
Price BSE
726.0
-
Price NSE
726.00
-
Market Capital( in Cr.)
1,697.44
-
P/C Ratio
30.90
-
P/E Ratio
57.80
-
Price Vs.BV
12.60
-
26-Apr-2025( 10:25)
Corporate News - Tatva... - Tatva Chintan Pharma Chem will...
-
28-Jan-2025( 04:58)
Results - Announcements - Tatva... - Net profit of Tatva Chintan Ph...
-
17-Jan-2025( 05:27)
Corporate News - Tatva... - Tatva Chintan Pharma Chem will...
-
25-Oct-2024( 06:37)
Results - Announcements - Tatva... - Net loss of Tatva Chintan Phar...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar | 2019 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 378.68 | 403.04 | 427.81 | 291.19 | 253.84 | 202.90 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 378.68 | 403.04 | 427.81 | 291.19 | 253.84 | 202.90 |
Other Income | 7.51 | 5.68 | 10.63 | 5.10 | 0.56 | 1.19 |
Stock Adjustments | 10.72 | -6.51 | 58.04 | 5.20 | 16.03 | 3.11 |
Total Income | 396.91 | 402.21 | 496.48 | 301.49 | 270.43 | 207.20 |
EXPENDITURE : | ||||||
Raw Materials | 178.76 | 215.82 | 254.49 | 153.53 | 146.16 | 118.29 |
Power and Fuel Cost | 34.78 | 23.61 | 22.62 | 9.92 | 8.96 | 6.25 |
Employee Cost | 54.76 | 41.21 | 30.82 | 23.80 | 20.53 | 16.31 |
Other Manufacturing Expenses | 19.59 | 18.03 | 23.95 | 16.45 | 15.30 | 8.02 |
Selling and Administration Expenses | 32.82 | 38.63 | 46.95 | 26.53 | 24.31 | 21.99 |
Miscellaneous Expenses | 1.67 | 8.01 | 1.01 | 0.76 | 1.91 | 1.96 |
Employee Benefit Expenses | 54.76 | 41.21 | 30.82 | 23.80 | 20.53 | 16.31 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 322.38 | 345.31 | 379.85 | 231.00 | 217.17 | 172.82 |
Operating Profit | 74.53 | 56.91 | 116.64 | 70.49 | 53.26 | 34.38 |
Interest | 6.66 | 8.52 | 5.19 | 4.41 | 4.25 | 3.94 |
Gross Profit | 67.87 | 48.39 | 111.45 | 66.08 | 49.01 | 30.44 |
Depreciation | 25.60 | 9.55 | 8.18 | 6.73 | 4.79 | 4.02 |
Profit Before Tax | 42.27 | 38.84 | 103.27 | 59.35 | 44.22 | 26.42 |
Current Tax | 0.01 | -2.80 | 18.01 | 10.43 | 8.11 | 4.55 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 12.91 | 1.17 | -10.73 | -2.44 | 1.15 | 1.69 |
Reported Net Profit | 29.35 | 40.47 | 95.99 | 51.36 | 34.96 | 20.19 |
Extraordinary Items | -0.06 | -3.31 | -0.04 | -0.03 | -0.02 | 0.57 |
Adjusted Net Profit | 29.41 | 43.78 | 96.03 | 51.39 | 34.98 | 19.62 |
Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | -12.05 | 0.00 | 0.00 |
P & L Balance brought forward | 273.91 | 237.88 | 141.89 | 106.61 | 71.64 | 51.46 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 4.68 | 4.43 | 0.00 | 4.02 | 0.00 | 0.00 |
P & L Balance carried down | 298.58 | 273.91 | 237.88 | 141.89 | 106.61 | 71.64 |
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 20.00 | 20.00 | 20.00 | 50.00 | 0.00 | 0.00 |
Dividend Per Share(Rs) | 2.00 | 2.00 | 2.00 | 5.00 | 0.00 | 0.00 |
Earnings Per Share-Unit Curr | 12.55 | 18.26 | 43.31 | 25.57 | 43.51 | 25.12 |
Earnings Per Share(Adj)-Unit Curr | 12.55 | 18.26 | 43.31 | - | - | - |
Book Value | 310.31 | 227.74 | 211.54 | 80.61 | 142.44 | 99.11 |
Book Value(Adj)-Unit Curr | 310.31 | 227.74 | 211.54 | - | - | - |